Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
BMC Cancer. 2015 Mar 25:15:173.
doi: 10.1186/s12885-015-1181-5.